Association between plane of mesocolic dissection and recurrence after complete mesocolic excision for right‐sided colon cancer: a cohort study
Colorectal Disease · 2023
DOI: 10.1111/codi.16551 ↗Kurz gefasst
Kohortenstudie in der Zeitschrift Colorectal Disease, 2023. Verfasst von Claus Anders Bertelsen und 5 weiteren Autor:innen. Beteiligte Einrichtung: Department of Surgery, Copenhagen University Hospital - North Zealand, 3400, Hillerød, Denmark. Hauptthemen laut MEDLINE: Adenocarcinoma, Colonic Neoplasms, Mesocolon, Laparoscopy. Die Arbeit wurde bisher 5-mal zitiert (Crossref) und nennt 27 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY-NC-ND 4.0). Gefördert von: Edgar & Hustru Gilberte Schnohrs Fond, Else & Mogens Wedell-Wedellsborg Fond, Helen Rudes Fond.
Abstract (Originalsprache)
Aim
Dissection in the mesocolic plane is considered by some medical professionals to be crucial in complete mesocolic excision. We aimed to assess whether intramesocolic plane dissection is associated with a risk of recurrence after complete mesocolic excision for right‐sided colon cancer.
Method
This is a single‐centre study based on prospectively registered data on patients undergoing resection for Union for International Cancer Control Stage I–III right‐sided colon adenocarcinoma during the period 2010–2017. Patients were stratified in an intramesocolic plane group or a mesocolic plane group based on a prospective assessment of fresh specimens by a pathologist. Primary outcome was the 4.2 year risk of recurrence after inverse probability treatment weighting and competing risk analyses.
Results
Of 383 patients, 4 (1%) were excluded as the specimen was assessed as muscularis propria plane, 347 (91.6%) specimens were deemed as mesocolic and 32 (8.4%) as intramesocolic. The 4.2 year cumulative incidence of recurrence after inverse probability treatment weighting was 9.1% (95% CI 6.0%–12.1%) in the mesocolic group compared with 14.0% (3.6%–24.5%) in the intramesocolic group with an absolute risk difference in favour of mesocolic plane dissection of 4.9% (−5.7 to 15.6, p = 0.37). No difference was observed in the risk of local recurrence, death before recurrence or overall survival after 4.2 years between the two groups.
Conclusion
Mesocolic plane dissection can be achieved in more than 90% of patients. The classification seems to be a guide for good surgical practice and not to be used for research purposes.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Autor:innen und Institutionen
- Department of Surgery, Copenhagen University Hospital - North Zealand, 3400, Hillerød, Denmark.
- Department of Clinical Medicine, Faculty of Health and Medical Sciences, University of Copenhagen, Copenhagen, 2200, Denmark.
- Department of Pathology, Copenhagen University Hospital-Herlev and Gentofte, Herlev, 2730, Denmark.
ORCID-Profile: Claus Anders Bertelsen
Förderung
- Edgar & Hustru Gilberte Schnohrs Fond
- Else & Mogens Wedell-Wedellsborg Fond
- Helen Rudes Fond
- Inger & Hakon Fabricius Fond
- KV Fonden
- Olga Bryde Nielsen Fond
- Tvergaard
Zitieren
APA
Bertelsen, C. A., Gundestrup, A. K., Olsen, A. S. F., Bols, B., Ingeholm, P., & Kleif, J. (2023). Association between plane of mesocolic dissection and recurrence after complete mesocolic excision for right‐sided colon cancer: a cohort study. Colorectal Disease. https://doi.org/10.1111/codi.16551
Vancouver
Bertelsen CA, Gundestrup AK, Olsen ASF, Bols B, Ingeholm P, Kleif J. Association between plane of mesocolic dissection and recurrence after complete mesocolic excision for right‐sided colon cancer: a cohort study. Colorectal Disease. 2023. doi:10.1111/codi.16551
BibTeX
@article{Bertelsen2023,
author = {Bertelsen, Claus Anders and Gundestrup, Anders Kierkegaard and Olsen, Anna Sofie Friis and Bols, Birgitte and Ingeholm, Peter and Kleif, Jakob},
title = {Association between plane of mesocolic dissection and recurrence after complete mesocolic excision for right‐sided colon cancer: a cohort study},
journal = {Colorectal Disease},
year = {2023},
doi = {10.1111/codi.16551}
}
EUVIMED